Zixiang, Wang – Trademark Portfolio
Entity Type: 01
Zixiang, Wang holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include SEARON, BRAPILOT, and UXENPHXF. The owner is based in Ningbo, Zhejiang.
Rm. 1006, No. 33, Bldg. 10
Yunluwan S. Area, Cicheng Town, Jiangbei
Ningbo, Zhejiang 315000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zixiang, Wang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Zixiang, Wang have?
Zixiang, Wang has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.
What trademark classes does Zixiang, Wang file in?
Zixiang, Wang files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Zixiang, Wang's most well-known trademarks?
Zixiang, Wang's registered trademark portfolio includes well-known marks such as SEARON, BRAPILOT, and UXENPHXF. These are among 5 currently registered trademarks in the portfolio.
What is Zixiang, Wang's trademark registration success rate?
Zixiang, Wang has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.